skip to main content

Classification systems for platelet-rich plasma

Rossi, L A ; Murray, I R ; Chu, C R ; Muschler, G F ; Rodeo, S A ; Piuzzi, N S

The bone & joint journal, 2019-08, Vol.101-B (8), p.891-896 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
  • Título:
    Classification systems for platelet-rich plasma
  • Autor: Rossi, L A ; Murray, I R ; Chu, C R ; Muschler, G F ; Rodeo, S A ; Piuzzi, N S
  • É parte de: The bone & joint journal, 2019-08, Vol.101-B (8), p.891-896
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: There is good scientific rationale to support the use of growth factors to promote musculoskeletal tissue regeneration. However, the clinical effectiveness of platelet-rich plasma (PRP) and other blood-derived products has yet to be proven. Characterization and reporting of PRP preparation protocols utilized in clinical trials for the treatment of musculoskeletal disease is highly inconsistent, and the majority of studies do not provide sufficient information to allow the protocols to be reproduced. Furthermore, the reporting of blood-derived products in orthopaedics is limited by the multiple PRP classification systems available, which makes comparison of results between studies challenging. Several attempts have been made to characterize and classify PRP; however, no consensus has been reached, and there is lack of a comprehensive and validated classification. In this annotation, we outline existing systems used to classify preparations of PRP, highlighting their advantages and limitations. There remains a need for standardized universal nomenclature to describe biological therapies, as well as a comprehensive and reproducible classification system for autologous blood-derived products. Cite this article: 2019;101-B:891-896.
  • Editor: England
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.